Barbara Ryan | Investor Relations |
Robert Ward | Chairman and Chief Executive Officer |
Greg Williams | Chief Operating Officer |
Susan Schneider | Senior Vice President, Clinical Development-Ophthalmology |
Greg Weaver | Chief Financial Officer |
David Snow | Chief Business Officer |
Joel Beatty | Citi |
Ted Tenthoff | Piper Jaffray |
Fang-Ke | SunTrust Robinson Humphrey |
Good morning, everyone, and welcome to Eloxx Pharmaceuticals' First Quarter 2019 Earnings Webcast and Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Barbara Ryan, Eloxx' Investor Relations Officer. Please begin.
Thank you, Liz.